Introduction

45
Head and neck cancer (HNC) is the seventh most common non-skin cancer worldwide with an estimated 700,000 new 46 cases diagnosed annually [1] . Survival of head and neck cancer (HNC) remains low despite advanced treatment 47 modalities [1] , whereby the stage of disease markedly affects survival [3] . Many studies support the notion that delays 48 affect survival [2] [3] [4] [5] [6] . The underlying causes are multifactorial and require evaluation. General practitioners (GP) play a 49 crucial role in symptom recognition and cancer diagnostics [7] . Further, patients' response to bodily sensations and 50 symptoms vary, thus affecting their search for medical care [8] . Patients with early stage disease can often be managed 
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Much effort is placed on minimizing hospital delays [5, [10] [11] [12] . A recent study on hospital delays in a sample of more 63 than 50,000 HNC patients showed that delays from diagnosis to the initiation of curative treatment independently 64 affected survival [13] . In addition, a meta-analysis concluded that with each month without treatment, the relative risk 65 of death was increased by 1.16 [14] . 66 67 Delays may occur before patients seek medical care. Patient-related delays in the management of HNC as well as the 68 underlying causes for these remain relatively unknown. A review of oral cancer showed that patient-related delay 69 represents the most important factor influencing delay before treatment [15] . Socioeconomic factors and behavioral 70 tendencies, such as the heavy use of alcohol, appear to associate with delay [16] [17] [18] . In addition, tumor site, the 71 presence of symptoms and the heterogeneity and duration of symptoms before seeking medical care all influence delays 72 3 [19] [20] [21] . Thus, patients with mild symptoms or no perception of malignancy may seek medical attention later and may 73 present with advanced disease [22, 23] . Investigating the underlying causes for delay provides a possibility to discover 74 means to shorten these delays. It seems reasonable to assume that any effort to decrease patient and treatment delays 75 will improve cancer diagnosis at an earlier stage, thereby resulting in a better prognosis.
77
In this study, we examined the lengths and causes for delays before referral to ENT department, that is, patient and PHC 78 delays -in a one-year cohort of all new, consecutive HNC patients treated at our institution.
80
Patients and methods
81
We included all new adult HNC patients, but not those with thyroid cancer, treated at the Department of 82 Otorhinolaryngology -Head and Neck Surgery at the Helsinki University Hospital over a one-year period (January 14, 83 2015 through January 14, 2016). Our tertiary care center is the main specialist-care HNC center in Southern Finland 84 with a referral area of 1.9 million inhabitants. To collect our data, we used a patient questionnaire and hospital records.
85
In addition, we did not include patients with a previous HNC and patients incapable of understanding or completing the 86 questionnaire (due to, for example, dementia). The self-administered questionnaire was distributed after the cancer 87 diagnosis before definitive treatment or in case patient did not return the questionnaire during outpatient clinic (Table 1 ). We used 98 commonly applied dose limits to measure the excessive use of alcohol (15 or more drinks per week for men and 8 or 99 4 more drinks per week for women) [24] . Tumor sites were documented according to ICD-10 classification codes, while 100 TNM classification adhered to the seventh edition of the UICC cancer staging manual [25] . For our analysis, we 101 grouped tumor sites as follows: oral cavity, oropharynx, hypopharynx, nasopharynx, larynx (differentiating glottic, 102 supraglottic, subglottic and transglottic subsites), nose and paranasal sinuses, major salivary glands and unknown 103 primary. In addition, tumors were divided into three groups based on histological types: squamous cell carcinomas 104 (SCC) and its variants, salivary gland carcinomas and others. Table 2 summarizes the tumor-related characteristics.
106
We also used the following time intervals in our analysis: 1. Patient delay represents the time period from the 107 appearance of the first symptom to the initial contact with a health care provider; 2. PHC delay represents the time 108 period from the patient´s first contact with a health care provider to receiving the referral to specialist-care treatment 109 ( Figure 1 ). For this study, we used the term 'total delay before referral to specialist-care Department of 110 Otorhinolaryngology -Head and Neck Surgery (ENT Department)' (TD), which included both patient and PHC delays.
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We double-checked the delay data from hospital records which are based on the interview at the initial visit to our ENT 112 Department, where the doctor typically asks about the duration of symptoms. If there was a major difference in delay 113 times between these two sources of information, we used the information found in hospital records as it is documented 114 before the cancer diagnosis. This source of information was preferred to better avoid recall bias and patients' potential 115 fear of being judged by doctors for postponing their search for medical care, when the nature of the disease is revealed.
116
In most of the cases the delay information received from questionnaires were in line with the data found in hospital 117 records. In our analysis, we compared these three delay parameters to patient symptoms as well as to patient and tumor 118 characteristics. PHC delay was analyzed separately according to the initial place of visit: GP, private 119 otorhinolaryngologist, dentist or hospital emergency department.
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We used SPSS version 24 (SPSS, Inc., Chicago, IL, USA) for all statistical analyses. The distributions of delays skewed 122 to the right, since most patients reported shorter delays than the average. Therefore, we employed nonparametric tests in 123 our statistical analysis. When analyzing the delay in two independent groups, we employed the Mann-Whitney U-test; 124 when analyzing more than two independent groups, we employed the Kruskall-Wallis test. 
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During the study period, 202 new HNC patients were referred to our department. From these, 6 patients refused to 137 participate in the study, 22 patients did not return the questionnaire and 32 patients did not fulfil the inclusion criteria 138 for several reasons. Patients were not included because they were incapable of understanding the questions due to 139 dementia (n = 12), they were unable to speak Finnish or Swedish (n = 8), they had a previously diagnosed HNC (n = 6), 140 they presented in a poor overall condition (n = 3) or they were incapable of completing the questionnaire due to other 141 factors (n = 3). The remaining 142 patients completed the questionnaire and formed our study cohort.
143
Among the 142 patients in our study, 104 (73%) were men and 38 (27%) were women with a mean age of 62 years 144 (range, 21--86). Table 1 summarizes other patient-related factors. SCC and its variants comprised most of the tumors (n 145 = 117; 82%), and the most common site was the oropharynx (n = 47; 33%). The median patient delay was 35 days (mean, 128 days; range, 0 days--8.9 years; Figure 2 ). The patient delay was less 154 than three months for 72.5% of patients. We found no significant correlation between patient characteristics and patient 155 delay (Table 1) . Age did not have a statistically significant correlation with patient delay (rs=0.031, p=0.715), primary 156 health care delay (rs=-0.029, p=0.733), or TD (rs=0.031, p=0.713). However, patient delay was significantly associated 157 with tumor site and nodal disease (Table 2) , and with specific symptoms: hoarseness and difficulties breathing resulted 158 in longer delays, whereas patients reporting a lump on the neck associated with significantly shorter delays (Table 3 ).
160
The median PHC delay was 20 days (mean, 98 days; range, 0 days--14 years) and 27% of patients sought medical 161 advice within a week after noticing symptoms. Overall, the PHC delay was less than 3 months in 78.9% of patients. The 162 initial place of visit significantly impacted the PHC delay (p = .016). More specifically, patients who contacted a private 163 otorhinolaryngologist (n = 21) had a significantly shorter PHC delay before referral to ENT department than those who 164 contacted a GP (n = 97; p = .027). Among all patients, 97 (73%) initially contacted a GP, 21 (16%) a private 165 otorhinolaryngologist, 8 (6%) a hospital emergency department and 7 (5%) a dentist. Among patients grouped by initial 166 contact point, the median PHC delays were 21, 4, 17 and 24 days, respectively. The remaining 9 patients did not report 167 these data. Overall, TD, which included both patient and PHC delays, was less than 3 months in 53.5% of patients.
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At the initial visit, 74 (55%) patients were referred directly to our ENT department, 29 (21%) received treatment or 170 further examinations through a scheduled new appointment, 11 (8%) received treatment without any further 171 appointments and 21 (16%) received no treatment or follow-up visits. The remaining 7 patients did not report these 172 data. Patients referred for specialist treatment or who received a new appointment at the initial visit had a significantly 173 shorter median PHC delay than patients who received no follow-up visits (14 days vs. 102 days; p < .001). On average, 174 patients had 2 (mean 2.4) visits to a physician before a referral for specialist treatment. The number of visits 175 significantly correlated with the PHC delay (p < .001). In addition, 55 (39%) patients had 1 visit, 33 (23%) 2 visits, 17 176 (12%) 3 visits, 14 (10%) 4 visits and 10 (7%) 5 or more visits. The remaining 13 patients did not report these data. The 177 median PHC delays in these groups of patients were 11, 20, 35, 50 and 175 days, respectively. Regarding patients' 178 perception of the GPs expression of the disease, 55 (39%) patients reported that the disease was considered benign by 179 the physician at the initial visit, 29 (21%) were told they had a possible malignancy and 56 (40%) expressed no opinion.
180
Two patients did not report these data.
182
Multivariable analysis (Table 4 ) revealed that patient delay and total delay in stage 0-II disease were significantly 183 longer than in stage III-IV disease. Patients, who contacted a private otorhinolaryngologist had significantly shorter 184 PHC delay than patients who contacted a GP. PHC delay and TD were shorter among patients, who had 1-3 visits 185 before referral to ENT Department than those who had 4 visits or more. 
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However, using the mean rather than the median delay can be misleading, since delays are not normally distributed. In 201 our cohort, the majority (79%) of patients had a shorter delay than the mean, while a few patients reported very long 202 delays of more than a year (Table 5) 
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In addition, we found that none of the sociodemographic factors (age, sex, education, employment, place of residence) 225 affected delay times, a finding consistent with other studies [6, 19, 20, 26, 28] . In our cohort, excessive alcohol 226 consumption did not correlate with patient delay since both current and previous heavy drinkers exhibited similar delays 227 compared to moderate drinkers and those who reported complete abstinence. Based on our study, we may only 228 speculate the possible reasons why alcohol use may alter medical care seeking behavior. Other studies found an 229 association between excessive alcohol consumption and longer patient delay [16, 17] . Our study also revealed no 230 correlation between tobacco smoking and patient delay. In two other studies, heavy smokers had generally shorter 231 patient delay than light smokers [16, 20] . Brouha et al. [16] suggest that this finding might be explained by the fact that 232 heavy smokers acknowledge their increased risk for HNC and are more aware of any possible signs and symptoms of 233 cancer. Yet, Väisänen et al. [23] reported that almost 50% of patients who smoke remained oblivious to this risk.
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Furthermore, we found no impact from patient employment on patient delay. In the literature, findings regarding the 235 effect of socioeconomic status on patient delay vary. Some researchers reported that a lower socioeconomic status leads 236 to longer patient delays [28, 29] , although a study from Great Britain did not support this hypothesis [20] . Similar to 237 findings from Great Britain, however, the Finnish national public health care system allows patients to seek medical 9 care regardless of income, which may explain these differences across studies [20, 28, 29] . In our cohort, educational 239 level and delays were not correlated, a finding consistent with Noonan et al. [28] . Patients' psychological and 240 psychosocial factors influence health behavior but for practical reasons they were not examined in this study [30, 31] . [6, 19, 23, 26] . Patients with a salivary gland carcinoma, which tends to grow slowly, reported considerably longer 251 PHC delay in our cohort than those with SCC. We found no correlation between T class and patient delay, a finding 252 consistent with other studies [19, 23, 26] . At some sites, tumors can become fairly large before causing any notable 253 symptoms, while the severity and emergence of symptoms vary. A positive N class tumor correlated with shorter patient 254 delay and TD, which represented the primary cause of the correlation between more advanced disease stage and a 255 shorter delay. The association between the stage of the disease and patient delay has been extensively studied with 256 varying findings [6,10,21,23, 26, 27] . Patients may also experience various symptoms and the intensity of symptoms in a 257 different way, which might affect the latency to seek for medical care [8] .
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The type of first contact with medical care patients reported played a crucial role in their referral to specialist care. A 260 visit to a private otorhinolaryngologist more often resulted in a referral to a specialist for treatment during the initial 261 visit with a significantly shortened PHC delay than after visiting a GP. In addition, patients with a scheduled follow-up 262 appointment had a significantly shorter median PHC delay (14 vs. 102 days), a finding consistent with a similar study 263 [32] . Too often, a patient's symptoms are interpreted as benign or treated as an infection ( 
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Our study allowed for a structured and comprehensive data collection method. Yet, this also carries some limitations.
272
As such, some patients were unable to complete the questionnaire for various reasons and were, therefore, not included 273 in the study. Among these patients, palliative treatment was significantly more common (27% vs. 3%). At least some of 274 these patients who did not fulfil the inclusion criteria would most likely have a longer delay due to their general health 275 condition. Nevertheless, the cohort still included 70% of the annual HNC patients treated at our tertiary care center. The 276 patient questionnaire was administrated after cancer diagnosis, which might have had an influence on the patient's 277 ability to accurately recall the onset of symptoms and lead to falsely reconstructed sequence of events as the outcome is 278 known. In order to minimize recall bias, the delay data were double-checked from hospital records. Furthermore, the 279 recall bias might vary between different symptoms, as some symptoms are more noticeable than others. In addition, 280 patient reported data are always subjective, and, thus, open to interpretation. Furthermore, if a patient reported multiple 281 symptoms, the sequence of the emergence of symptoms remained unclear. Our study also includes patients who 282 experienced a delay of more than a year (Tables 5 and 6 ). This highlights the need for continuous education and 283 awareness raising of disease and possible cancer-related symptoms among both the general population and health care 284 personnel. We did not investigate the effect of p16/HPV status in this study, because it has role only in certain tumor 285 sites, almost exclusively in the oropharynx. Furthermore, the number of patients with some tumor sites remained 286 limited. Therefore, our analysis of delays in patients presenting with tumors at different subsites calls for further study.
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In conclusion, we show that symptoms, tumor-related factors and decisions made during the first contact with health 289 care providers influence delay before specialist consultation. The majority of patients seek medical care fairly early and 290 exceptionally long delays were fairly rare. Raising awareness of HNC symptoms among general population and GPs is 291 the way to get patients to curative treatment without long delay. 
